Remove Immunity Remove Mayo Clinic Remove Vaccines
article thumbnail

Pharmacists Take the Lead on Advanced Therapeutics

Pharmacy Times

Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. Still, confusion remains over the role of pharmacy and therapeutics (P&T) committees in this process. This governance issue is a very hot topic,” Eric M.

20
article thumbnail

Innovation in immuno-oncology: Leading companies in oncolytic viral proteins

Pharmaceutical Technology

Its platform has capabilities to be used in combination with CAR-T and other cell therapies to overcome poor immune cell infiltration, immunosuppressive properties of tumour microenvironment, and systematic toxicity issues. The company has an operational presence in the US and the UK (headquartered in Abingdon, Oxfordshire, UK).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading innovators in HIV peptides for the pharmaceutical industry

Pharmaceutical Technology

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These can serve as an important component of a vaccine.

article thumbnail

ASCO 2025: Promising Safety and Efficacy of Encorafenib and Binimetinib in Resected Stage II Melanoma

Pharmacy Times

Mayo Clinic. Akkooi A, Mandala M, Kicinski M, Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation. J   Clin Oncol. 43, 2025 (suppl 17; abstr LBA9500). doi:10.1200/JCO.2025.43.17_suppl.LBA9500.

26